Targeting Amyloid and Tau: Current and Emerging Therapies

The pathological accumulation of amyloid-beta plaques and tau tangles remains a hallmark of Alzheimer’s disease. This session will explore current therapies targeting amyloid and tau, as well as novel strategies in development. The discussion will cover FDA-approved drugs, such as anti-amyloid monoclonal antibodies, and new clinical trial results from drugs aiming to halt or reverse tau pathology. By addressing these core pathologies, this track will focus on how therapeutic interventions may modify disease progression.
 

    Related Conference of Targeting Amyloid and Tau: Current and Emerging Therapies

    April 10-11, 2025

    6th Annual Congress on Psychiatry

    Dubai, UAE
    April 14-15, 2025

    3rd World Congress on Psychiatry

    Budapest, Hungary
    May 21-22, 2025

    7th European Autism Congress

    Paris, France
    June 16-17, 2025

    3rd International Conference onPsychiatry and Psychology

    Zurich, Switzerland
    June 16-17, 2025

    10th International Conference on Addiction Therapy

    Zurich, Switzerland
    June 16-17, 2025

    35th Euro Congress on Psychiatrists and Psychologists

    Frankfurt, Germany
    June 19-20, 2025

    5th Annual Congress on Mental Health

    Paris, France
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 20-21, 2025

    9th International Conference on Forensic Psychology & Criminology

    Aix-en-Provence, France
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France

    Targeting Amyloid and Tau: Current and Emerging Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in